Skip to main content

biotech-blood-lab-rgb

Venture investor Krishna Yeshwant uses a healthy amount of skepticism when vetting potential companies to invest in. His favorite time to invest is when one of his partners at the fund is excited about a particular company, even if nobody else is.

{iframe}https://www.businessinsider.com/gvs-krishna-yeshwant-on-skepticism-in-biotech-and-healthcare-investments-2018-8{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.